You are here: Industry Insights > OPKO Health

News List

OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test prnewswire
October 22, 2020
BioReference Laboratories, Inc., an OPKO Health company, is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the diagnosis of ...
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC) prnewswire
July 21, 2020
BioReference Laboratories, Inc., an OPKO Health company, announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the CDC.
OPKO Health’s Annual Report a Mixed Bag biospace
March 05, 2018
Miami-based Opko Health, Inc.’s fourth-quarter report highlighted positive activities in the face of a net loss of $213.9 million during the fourth quarter, compared to $147.7 million in the same period the year before.